REGISTERED NUMBER: 10209411 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

MB GLOBAL HEALTH LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Mr L De Laporte

Mr D W J Howcroft

REGISTERED OFFICE:

C/O Mainyard Studios Rookery Court

80 Ruckholt Road

London

E10 5FA

REGISTERED NUMBER:

10209411 (England and Wales)

ACCOUNTANTS:

Oury Clark Chartered Accountants

Herschel House

58 Herschel Street

Slough

Berkshire

SL1 1PG

CURRENT ASSETS

Debtors: amounts falling due within one year

4

2,868,747

1,201,081

Debtors: amounts falling due after more than one year

4

2,300

923,407

Cash at bank

906,931

521,553

3,777,978

2,646,041

CREDITORS

Amounts falling due within one year

5

5,997,708

4,235,625

NET CURRENT LIABILITIES

(2,219,730

)

(1,589,584

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(2,219,730

)

(1,589,584

)

CAPITAL AND RESERVES

Called up share capital

7

776

776

Retained earnings

(2,220,506

)

(1,590,360

)

SHAREHOLDERS' FUNDS

(2,219,730

)

(1,589,584

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 December 2025 and were signed on its behalf by:

Mr L De Laporte - Director

1.	STATUTORY INFORMATION

MB Global Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover

Turnover represents commission invoiced to the parent company. Commission is calculated at an agreed percent of the overall income (the net amount of received remuneration from third party customers reduced by the net amount of invoices received from third party service providers).

Turnover is recognised and invoiced on completion of service provided to third party customers.

Financial instruments

Basic Financial Instruments as covered by Section 11 of FRS102 are measured at amortised cost. The company does not have any Other Financial Instruments as covered by Section 12 of FRS102.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2023 - 11 ) .

4.

DEBTORS

31.12.24

31.12.23

£

£

Amounts falling due within one year:

Trade debtors

946,957

680,626

Other debtors

1,921,790

520,455

2,868,747

1,201,081

Amounts falling due after more than one year:

Amounts owed by group undertakings

2,300

923,407

Aggregate amounts

2,871,047

2,124,488

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Trade creditors

208,190

295,273

Amounts owed to group undertakings

5,727,730

2,864,461

Taxation and social security

16,799

25,675

Other creditors & accruals

44,989

1,050,216

5,997,708

4,235,625

6.	SECURED DEBTS

In September 2023, the company entered into a new fixed charge and negative pledge over its assets in favour of HSBC Innovation Banking.

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.24

31.12.23

value:

£

£

1,000

Ordinary

€1

776

776

8.	ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.

9.	ULTIMATE PARENT COMPANY

The immediate and ultimate parent company is MB Global Health GmbH, a company incorporated in Germany with registered office at Prinzessinnenstraße 26, 10969, Berlin, Germany. This is the largest and only group for which consolidated accounts are produced. Consolidated accounts are not publicly available.